Browsing: Amylin News
US pharmaceutical group Bristol-Myers Squibb Co (NYSE:BMY) said it had made an agreement to buy diabetes-focused biopharmaceutical firm Amylin Pharmaceuticals Inc (NASDAQ:AMLN) at U$31.00 (€24.50) in…
Amadeus House 27b Floral Street London WC2E 9DP United Kingdom
editor@financial-news.co.uk.
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Copyright © 2026 Financial News